openPR Logo
Press release

Animal Vaccine Market application analysis, regional outlook, growth trends by 2025 | Ceva Animal Health, Valneva Technologies, and Virbac S.A

01-08-2020 08:58 AM CET | Health & Medicine

Press release from: Orion Market Research

Animal Vaccine Market

Animal Vaccine Market

The global animal vaccine market is projected to grow at a CAGR of 6.5% during the forecast period (2018-2023). Though the awareness towards vaccinating animals is low in a number of developing countries, various government initiatives and vaccination programs by animal welfare organizations are driving the growth of global animal vaccine market. Establishment of national vaccination awareness month is one of the steps taken by the government to create awareness among the public towards animal health and welfare. For instance, National Vaccination Awareness Month is observed during the month of August in the US, that has been designed for raising awareness regarding the importance of pet immunization.

Get Sample Copy of Animal Vaccine Market at: https://www.omrglobal.com/request-sample/animal-vaccine-market

The major players that contribute to the growth of the Animal Vaccine market include - Zoetis, Elanco (Eli-Lilly), Merck & Co. Inc., Boehringer Ingelheim Bayer, Ceva Animal Health, Valneva Technologies, and Virbac S.A

Further, Health Officials in Canada and UK collaboratively started a new initiative in April 2018, to combat antimicrobial resistance (AMR) in livestock and aquaculture production in low- and middle-income countries. Global AMR Innovation Fund of UK government and International Development Research Centre (IDRC) of Canada through Innovet-AMR, a partnership will fund and support research for the development of new and innovative animal vaccines and other innovative veterinary solutions for reducing the use of antimicrobials in livestock and aquaculture in LMICs. It is a four-year initiative that is supported by $22.1 million. Globally, important antibiotics are commonly used in the production of food in high- as well as low-income countries in the animal vaccine industry.

Furthermore, one of the leading poultry farms, CHI Farm in Nigeria in September 2018, has announced to open a new diagnostic center with the support of Zoetis and Bill & Melinda Gates Foundation (BMGF). The new diagnostic center is a part of a three-year initiative for building a sustainable veterinary diagnostic network and animal health infrastructure in Nigeria through the African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative. The BMGF has funded a grant of $18.4 million, that will be used to upgrade more laboratories across the region. This will make veterinary services, and medicines accessible to the farmers in the region.

For More Information get A full report of Animal Vaccine is available at: https://www.omrglobal.com/industry-reports/animal-vaccine-market

Moreover, players operating in the global animal vaccine market are taking initiatives by launching awareness programs in low-income countries to raise awareness regarding animal health and welfare. For instance, Boehringer Ingelheim in December 2018, launched ‘LastMile’ initiative, which is an integrated solutions-driven program that is aimed at addressing crucial animal health challenges by making animal medical resources available in hard-to-reach areas. The initiative targets ruminants, such as sheep, goats, and cattle, and will further expand to poultry. The company established this initiative with support from the Global Alliance for Livestock Veterinary Medicines (GALVmed) and sponsored by Bill & Melinda Gates Foundation, for bridging gaps in access, availability, and awareness of animal healthcare solutions for smallholder farmers in Africa.

Global Animal Vaccine Market - Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Others

By Technology

• Live Attenuated Vaccine
• Killed/Inactivated Vaccine
• Recombinant Vaccines
• Others

Global Animal Vaccine Market - Regional

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy

Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
For More Information, Visit Orion Market Research

Source: Global Animal Vaccine Market

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Vaccine Market application analysis, regional outlook, growth trends by 2025 | Ceva Animal Health, Valneva Technologies, and Virbac S.A here

News-ID: 1891557 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion